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Aim We aimed to investigate correlations between uterine 
artery peak systolic velocity (AUtPSV), and placental vascu-
larization in groups of normal blood pressure (NBP) and hy-
pertensive disorders of pregnancy (chronic hypertension 
(CHT), gestational hypertension (GHT) and preeclampsia 
(PE)) alone or in combination with gestational diabetes mel-
litus (GDM), and hypothesized that AUtPSV rises when GDM 
complicates pregnancy hypertension.
Methods Placental 3-dimensional power Doppler indices, 
such as vascularization index (VI), flow index (FI), and vas-
cularization-flow index (VFI), and uterine artery peak systolic 
velocity (AUtPSV) were measured in CHT (N = 43), CHT+GDM 
(N = 15), GHT (N = 57), GHT+GDM (N = 23) and PE (N = 17) 
pregnancies, and compared to NBP (N = 109). Correlations 
were analyzed between vascularization indices, AUtPSV, 
pregestational BMI and adverse pregnancy outcome rates.
Results In our results VI was higher in CHT (P = 0.010), 
while FI was lower in CHT (P = 0.009), GHT and PE (P = 0.001) 
compared to NBP. In case of VFI, significant difference was 
found between CHT and GHT (P = 0.002), and NBP and PE 
(P = 0.001). FI was found prognostic for umbilical pH and 
neonatal birth weight. Pre-gestational BMI was significantly 
higher in GHT+GDM compared to GHT, and in CHT+GDM 
compared to the CHT group. As for AUtPSV, significant dif-
ference was found between NBP and CHT (P = 0.012), NBP 
and CHT+GDM (P = 0.045), NBP and GHT+GDM (P = 0.007), 
NBP and PE (P = 0.032), and GHT and GHT+GDM (P = 0.048) 
groups.
Conclusion Our study revealed that vascularization indices 
and AUtPSV show significant differences due to gestational 
pathology, and can be useful in detection of pregnancies 
at risk.
Use of placental vascularization 
indices and uterine artery 
peak systolic velocity in early 
detection of pregnancies 
complicated by gestational 
diabetes, chronic or 
gestational hypertension, and 
preeclampsia at risk
RECOOP for Common Mechanisms of Diseases 
 
Croat Med J. 2017;58:161-9 
https://doi.org/10.3325/cmj.2017.58.161 
RECOOP for Common Mechanisms of Diseases 162 Croat Med J. 2017;58:161-9
www.cmj.hr
Hypertension during pregnancy occurs in 5 - 7% of all 
pregnancies, and about 70% of them occur in first-time 
pregnancies (1). Chronic hypertension (CHT) is a complica-
tion in 1%-2% of all pregnancies, while gestational hyper-
tension (GHT) is a complication in 3%-6% of all pregnan-
cies (1-3). It can progress to preeclampsia (PE) in about 25% 
of cases, especially when hypertension presents before 32 
weeks of gestation (4). In Hungary, the prevalence of chron-
ic hypertension among pregnant women is 1%-2%, that of 
gestational hypertension is 3%-6% (3), and the prevalence 
of gestational diabetes mellitus (GDM) is 6%-9.5% (5).
Pregnancy hypertension is a leading cause of maternal and 
fetal morbidity and mortality; furthermore its pathophysi-
ological background is poorly understood (6).
Proper uterine and placental vascularization is important 
for the normal development of pregnancies (7,8). Patho-
logical fetomaternal circulation accompanying pregnan-
cy hypertension can lead to elevated resistance in uterine 
circulation, which can cause placental insufficiency and 
decreased fetal oxygenation (9), as a result of the patho-
logical changes in placenta. In diabetic pregnancies, the 
placenta also has morphological changes that may result 
in reduced uteroplacental perfusion (10,11). Placental hys-
tological maldevelopment can result in premature birth, 
intrauterine hypoxia, or even intrauterine death (12). These 
morphological changes can be detected indirectly by ul-
trasound in the form of vascularization indices (13).
Improvements in three-dimensional (3D) ultrasound have 
allowed us to obtain and study volumes from different or-
gans more precisely (14), and color map provided by power 
Doppler has made the study of vessels with low resistance 
much easier (15). Combining these techniques has enabled 
us to study the morphology of the vascular tree and to 
quantify the direct blood flow of the placenta (13,16).
Differences between placental vascularization indices in 
case of pregnancy hypertension complicated with GDM 
were unknown. It was also uclear whether there is dif-
ference in AUtPSV values depending on the presence of 
GDM, or not in case of pregnancy hypertension.
We hypothesized that placental vascularization and AUtPSV 
will differ depending on pregnancy pathology (CHT; GHT; 
GDM combined with CHT or GHT; and PE).
The purpose of the present study was to clarify the effect 
of using uterine artery peak systolic velocity (AUtPSV) mea-
surements, 3D ultrasound, and placental vascularization in-
dices on hypertensive disorders of pregnancy and hyper-
tensive disorders of pregnancy complicated with GDM in 
second and third trimesters.
PATIENTS AND METHODS
We performed a prospective Doppler study: placental 
vascularization indices and uterine artery peak systolic 
velocity. We included women with singleton pregnancies 
seen once in the second or third trimester at our outpa-
tient clinic at University of Szeged, Faculty of Medicine, 
Department of Obstetrics and Gynecology, in Szeged. 
Our study was carried out between 1 March 2014 and 31 
March 2015 in accordance with the Code of Ethics of the 
Declaration of Helsinki for scientific research involving 
humans, and our study was approved by the institutional 
research ethics committee (No.: 32/2014). Informed con-
sent was signed by the observed person after a detailed 
and clear explanation about the conditions and aims of 
the survey.
Patients
Inclusion criteria
In our study we analyzed singleton pregnancies between 
20-38 weeks of gestation, which were divided into six 
groups as you can see in Table 1. Gestational age was de-
termined on the basis of the first day of the last menstrual 
period and on the basis of the first trimester ultrasound 
biometry (biparietal diameter (BPD) and crown-lump 
length (CRL)).
TAblE 1. Groups of pregnant women and the number of cases examined
Groups of pregnant women No.of cases
NBP group of pregnant women with normal blood pressure 109
CHT group of pregnant women with chronic hypertension 43
CHT+GDM group of pregnant women with chronic hypertension complicated with gestational diabetes mellitus 15
GHT group of pregnant women with gestational hypertension 57
GHT+GDM group of pregnant women with gestational hypertension complicated with gestational diabetes mellitus 23
PE group of pregnant women with pre-eclampsia 17
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Diagnostic criteria for hypertension
High blood pressure (>140 mm Hg systolic or >90 mm Hg 
diastolic) was defined on the basis of the International Soci-
ety for the Study of Hypertension in Pregnancy (ISSHP) (4).
Blood pressure was measured (BP A100 PLUS, Microlife AG, 
Windau, St. Gallen, Switzerland) three times on each oc-
casion, and patients were scheduled for a check-up every 
two weeks.
Patients in the case groups had ongoing antihypertensive 
therapy with oral alpha-methyldopa 250 mg (Dopegyt, 
EGIS Pharmaceuticals 105 PLC., Budapest, Hungary) and 
they had dietary salt restrictions according to the Hungar-
ian guidelines (17).
Inclusion criteria for CHT was high blood pressure pre-dat-
ing pregnancy. As many women did not have their blood 
pressure measured before the pregnancy, we relied on the 
first trimester blood pressure according to ISSHP when de-
fining high blood pressure in these women. Inclusion crite-
ria for GHT was new onset of hypertension after 20 weeks 
of gestation, for which it was important to have normal 
blood pressure documented either before the pregnancy 
or at least in early pregnancy before pregnancy-related de-
crease in blood pressure occurred (4).
Diagnostic criteria for preeclampsia
In the diagnosis of PE we applied the definition of ISSHP 
(4), which defines PE as a combination of new onset of 
hypertension, that occurs after 20 weeks of gestation and 
the coexistence of one or more of the following new-on-
set conditions such as proteinuria, other maternal organ 
dysfunctions (renal insufficiency, liver involvement, neu-
rological or hematological complications) and uteropla-
cental dysfunction in the form of fetal growth restriction 
(IUGR).
Diagnostic criteria for GDM
GDM was defined on the basis of the recommendation of 
the World Health Organization (WHO) 2013 (18). In Hunga-
ry patients are screened with an oral glucose tolerance test 
(OGTT) containing 75 mg oral carbohydrate on the basis of 
WHO guidelines. Groups CHT+GDM and GHT+GDM con-
sisted of patients who had dietary sugar and salt restriction 
in addition to the antihypertensive therapy. Their blood 
glucose and HgA1c levels were in normal range. Those pa-
tients, in which introduction of insulin therapy was need-
ed, were excluded from the study. All pregnant women 
with GDM had normal glycemic response. We used HgA1c 
for GDM follow up. Body mass index (BMI) was defined as 
follows: underweight: <19 kg/m2; obese: >30 kg/m2.
Methods
Ultrasound diagnosis
Pregnant women who visited our outpatient clinic had 
been prospectively enrolled into 6 groups as follows: a 
control group (N = 109) and 5 case groups (N = 155). Those 
who did not meet the criteria of the study design during 
the study period were excluded (N = 612).
An initial 2D conventional ultrasound study provided data 
about fetal position and presentation, body movements 
and fetal heart rate, placental localization, umbilical cord 
insertion, and volume of amniotic fluid. All patients were 
scanned in a semi-recumbent position.
Examination started with fetal biometry in 2D mode ultra-
sound to assess biparietal diameter (BPD), head circumfer-
ence (HC), abdominal circumference (AC), femur length 
(FL) and to calculate estimated fetal weight (EFW) with the 
help of formula B of Hadlock (19), followed by color Dop-
pler study of the uterine arteries (20).
To identify the uterine arteries, we obtained a sagittal sec-
tion of the uterus, and used color flow mapping for AUtPSV 
(cm/s) (Figure 1). Then we applied pulsed wave Doppler 
with the sampling gate set at 2 mm. The angle of in-
FIGurE 1. Measurement of uterine artery peak systolic velocity 
(AutPSV) taken from the sagittal section of the uterus with 
color flow mapping and applied pulsed wave Doppler. PSV 
value is highlighted in red.
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sonation was <30º and we recorded at least three consec-
utive uniform waveforms (21). The impact of placentation 
on AUtPSV was ruled out by calculating the average value 
of the left and right uterine artery.
The next step was the 3D scan of the placenta at the in-
sertion point of the umbilical cord. We used 3D rendering 
mode, in which the color and gray value information was 
processed and combined to give a 3D image (mode cent: 
smooth, 4/5; FRQ, low; quality, 16; density, 6; enhance, 16; 
balance, 150; filter, 2; actual power, 2 dB; pulse repetition 
frequency, 0.9) (22). Power Doppler window (pulse repeti-
tion frequency at 900 Hz and wall filter of 50 Hz) was placed 
over the placenta, mapping the vascular tree from basal to 
chorionic plates, as this technique shows higher sensitivity 
because it is based on amplitude instead of mean frequen-
cies to depict the vascular tree (15). Moreover, color map-
ping is independent of the angle of insonation and does 
not show ‘aliasing’. However, it is more sensitive to patient 
movements, so the volumes should be acquired while 
avoiding any probe or patient movements; otherwise ar-
tifacts could be present.
The 3D static volume box was placed over the highest vil-
lous vascular density zone at umbilical cord insertion (23). 
The sweep angle was set at maximum 70°. The three planes 
of the acquired placental volume were explored to localize 
the zone where the highest vascular density was found by 
power Doppler mode. Volume acquisition was made dur-
ing a time interval varying from 5 to 10 s in the absence 
of fetal movements and with the mother staying as still as 
possible. We used fast low resolution acquisition to avoid 
any kind of artifacts. The variation in acquisition time was 
also dependent on the size of the volume box, and it cor-
related with the age of gestation.
All 2D and 3D ultrasound scans were performed  using Volu-
son 730 system (RAB 2-5 MHz transducer, GE Healthcare, 
Kretztechnik, Zipf, Austria). The same pre-established instru-
ment power settings were used in all cases (‘Obstetrics/2–3 
trimester’ in 2D mode).
Calculation of 3-dimensional power Doppler indices
Volume files were analyzed using the virtual organ com-
puter-aided analysis (VOCAL) program pertaining to the 
computer software 4D VIEW (GE Medical Systems, Austria, 
version 10.4) by an expert in 3D analysis.
We used Mercé-type sono-biopsy (23), a reproducible, 
valid alternative for evaluation of the vascular tree of 
the entire placenta (24,25). The spherical sample volume 
was 28 mL constantly, and the VOCAL software automati-
cally calculated the color scale values in a histogram, and 
the vascularization indices (vascularization index (VI), flow 
index (FI) and vascularization flow index (VFI)) from the ac-
quired spherical sample volume in all cases (23).
The 2D and 3D ultrasound acquisitions were performed at 
the same time, and 3D volume files were analyzed by VO-
CAL at a later time. The ultrasound images of 2D and 3D 
scans were stored on a hard disk (HD).
Data collection after delivery
Data about neonatal outcome and mode of delivery (nor-
mal delivery, planned cesarean section or acute cesarean 
section) were collected and classified after delivery. We 
collected data on 1-, 5-, and 10-minute Apgar scores, um-
bilical pH, neonatal birth weight, rate of neonatal com-
plications such as apnea, polycythemia, hypoglycemia, 
respiratory distress syndrome, dysmaturity and feeding dif-
ficulties, and the rate of macrosomia and premature birth.
Statistical analysis
Statistical analyses were performed with IBM SPSS Statis-
tics 21.0 for Windows program (IBM, New York, USA). Kol-
mogorov-Smirnov test results were significant for our da-
tabase demonstrating that our study samples were not 
normally distributed. Continuous variables were expressed 
as median ± standard deviation. The Kruskal-Wallis test was 
used for the comparison of continuous variables in the 
six groups examined, whereas comparison between the 
pathological groups was performed with Mann-Whitney 
U test in case of vascularization indices, and with Bartlett’s 
test with Bonferroni’s modification in case of AUtPSV, (level 
of significance was set at P < .05). Univariate comparisons 
for categorical variables were assessed with χ2 tests. Lin-
ear regression coefficient values and equations depend-
ing on gestational age were also calculated for VI, FI, VFI 
and AUtPSV for all pathological and control groups. The 
association between placental 3D power Doppler indices, 
AUtPSV, pre-gestational BMI, neonatal birth weight and 
pregnancy outcome, 2-D color Doppler indices (PIs of um-
bilical and uterine arteries) was determined by Spearman’s 
rank correlations.
rESulTS
The analysis of 3D volume acquisition demonstrated that VI 
indices are significantly lower  in CHT (P = 0.010), CHT+GDM 
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(P = 0.054), and GHT+GDM (P = 0.973) groups compared 
to NBP (Table 2). In case of GHT, VI was lower (P = 0.152) 
compared to NBP, though the difference was not signifi-
cant. There was significant difference between the CHT 
and GHT groups (P = 0.010). All PE cases evolved from GHT 
cases, therefore we analyzed the changes in 3-DPD indices, 
TAblE 2. Three-dimensional Power Doppler indices: vascularization index (VI), flow index (FI), and vascularization flow (VFI) index, 
and uterine artery peak systolic velocity (AutPSV) in pregnancies with normal blood pressure (NbP), chronic hypertension (CHT), 
chronic hypertension and gestational diabetes mellitus (CHT+GDM), gestational hypertension (GHT), gestational hypertension and 
gestational diabetes mellitus (GHT+GDM), and preeclampsia (PE)
Groups of pregnant women
Parameter CHT+GDM (n = 15) CHT (n = 43) NbP (n = 109) GHT (n = 57) GHT+GDM (n = 23) PE (n = 17)
VI (%, mean±SD)  5.3 ± 3.5 14.4 ± 10.1 10.4 ± 6.2 7.7 ± 7.1  5.4 ± 2.4  4.9 ± 3. 2
FI (mean±SD) 42.8 ± 9.6 41.5 ± 8.2 46.1 ± 7.6 38.5 ± 9.6 36.4 ± 8.3 36.5 ± 5.7
VFI (mean±SD)  2.3 ± 1.5  3.6 ± 2.8  4.1 ± 2.5  3.0 ± 2.5  2.0 ± 1.1  2.0 ± 1.6
AUtPSV (cm/s, mean±SD) 45.3 ± 14.1 50.0 ± 16.6 59.5 ± 23.1 56.8 ± 18.4 68.6 ± 30.9 52.4 ± 13.0
TAblE 3. Maternal and fetal characteristics in pregnancies with normal blood pressure (NbP), chronic hypertension (CHT), chronic hy-
pertension and gestational diabetes mellitus (CHT+GDM), gestational hypertension (GHT), gestational hypertension and gestational 
diabetes mellitus (GHT+GDM) and preeclampsia (PE)
Groups of pregnant women
Parameter
CHT+GDM 
(n = 15)
CHT 
(n = 43)
NbP 
(n = 109)
GHT 
(n = 57)
GHT+GDM 
(n = 23)
PE* 
(n = 17)
Mean maternal age (years; mean±SD) 34.4 ± 1.4 32.8 ± 4.2 30.7 ± 4.7 31.1 ± 5.4 32.5 ± 6.3 29.5 ± 5.2
P 0.023* 0.037*
Weeks of gestation at the time of 3D scan (mean±SD) 28+1±7+2 28+5±6+6 24+6±7+2 31+6±6+4 29+6±7+5 31+2±7+1
Weeks of gestation at the time of delivery (mean±SD) 37+4±1+5 38+5±1+1 38+3±1+6 38+0±2+2 37+1±2+3 36+6±3+5
Pregestational BMI (kg/m2; mean±SD) 32.8 ± 3.6 30.8 ± 4.6 30.7 ± 5.2 31.0 ± 5. 0 33.4 ± 7.1 27.2 ± 6.10
P 0.041* 0.047*
Number of women with pregestational maternal obesity 
(BMI over 30)
9/15 25/43 18/109 14/57 10/23 7/17
Weight gain during pregnancy until delivery (kg; mean±SD) 7.75 ± 7.02 8.45 ± 4.52 7.86 ± 4.95 13.44 ± 5.77 14.50 ± 4.53 11.41 ± 3.49
P <0.001* <0.001* 0.011*
Number of premature births 1/15 3/43 8/109 7/57 5/23 8/17
Apgar score 1-minute 8.30 ± 0.75 8.93 ± 1.09 8.86 ± 0.57 8.69 ± 1.52 8.21 ± 1.75 8.14 ± 1.43
(mean±SD) 5-minute 9.53 ± 0.66 9.68 ± 0.84 9.50 ± 0.67 9.65 ± 0.68 9.39 ± 1.15 9.29 ± 1.13
10-minute 9.93 ± 0.27 9.91 ± 0.35 9.91 ± 0.21 9.82 ± 0.60 9.65 ± 1.07 9.55 ± 0.84
Umbilical pH (mean±SD) 7.29 ± 0.05 7.23 ± 0.07 7.27 ± 0.08 7.26 ± 0.07 7.25 ± 0.07 7.25 ± 0.07
Number of 
perinatal 
complications
Apnea 7/15 3/43 9/109 6/57 5/23 7/17
P <0.001* 0.001* <0.001*
Polycythemia 0/15 2/43 7/109 7/57 0/23 2/17
Hypoglycemia 6/15 1/43 2/109 2/57 4/23 3/16
P 0.012‡ 0.022§
Respiratory distress syndrome 0/15 0/43 0/109 0/57 2/23 3/16
DysmaturityII 0/15 0/43 3/109 4/57 1/23 12/17
Feeding difficulties 6/15 1/43 7/109 4/57 5/23 0/17
P <0.001* 0.002*
Neonatal birth weight (grams; mean±SD) 3130 ± 296 3377 ± 374 3346 ± 555 3236 ± 751 3601 ± 811 2422 ± 817
Rate of macrosomia (neonatal birth weight over 4000g) 2/15 2/43 12/109 3/57 1/23 0/17
*All cases were intrauterine growth restriction.
†vs normal blood pressure (NbP) group.
‡CHT+GDM vs CHT.
§GHT vs GHT+GDM.
IISyndrome of an infant born with relative absence of subcutaneous fat, wrinkling of the skin, prominent finger and toe nails, and meconium stain-
ing of skin and placental membranes; often associated with postmaturity or placental insufficiency.
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but the difference between GHT and PE groups in case of 
VI was not statistically significant (P = 0.175).
In comparison with NBP group, FI was significantly lower 
in CHT (P = 0.009), CHT+GDM (P = 0.010), GHT (P < 0.001), 
GHT+GDM (P < 0.001), and PE (P < 0.001) groups; how-
ever, there was no statistically significant difference be-
tween CHT and CHT+GDM (P = 0.354); GHT and GHT+GDM 
(P = 0.443); and GHT and PE (P = 0.183) groups.
For VFI, no significant difference was found between 
CHT and CHT+GDM (P = 0.073) or NBP (P = 0.973), GHT 
and GHT+GDM (P = 0.428), GHT and PE (P = 0.128) or GHT 
and NBP (P = 0.075). Statistically significant difference 
can only be described when PE was compared to NBP 
(P = 0.010).
AUtPSV showed significant difference between NBP and 
CHT (P = 0.012) and GHT and GHT+GDM (P = 0.048) groups, 
but not between CHT and CHT+GDM (P = 0.062), GHT and 
NBP (P = 0.087), and GHT and GHT+GDM (P = 0.320).
Pre-gestational BMI was significantly higher (P = 0.009) in 
GHT+GDM (33.46 ± 7.11) compared to GHT (30.37 ± 5.80), 
as well as in CHT+GDM (32.84 ± 3.64) compared to the 
CHT (30.55 ± 5.68) group. Strong positive linear correlation 
was found between VI (P = 0.009), FI (P = 0.007) and neona-
tal birth weight (BW). Mean FI was 45.7 in case of normal 
pregestational BMI and 41.2 in case of elevated BMI, thus 
elevated pregestational BMI had substantial influence on 
FI depression (P = 0.048) and fetal growth development, 
consequently on BW.
Maternal and perinatal characteristics and pregnancy out-
comes included the maternal age, physique, lenght of 
gestation, the neonatal biophysical parameters, adapta-
tion parameters and complication of intrauterine chronic 
hypoxia (Table 3). We also analyzed mode of labor (Figure 
2) and gestational ages at 3-DPD ultrasound investigations 
(Figure 3) with respect to blood pressure and other inves-
tigated patology.
Interestingly the highest cesarean section rate was ob-
served in the GHT+GDM group, even in the PE group the 
rate of normal delivery was three times higher than in 
GHT+GDM, although premature birth rate was the high-
est in PE. All PE cases were consisted of patients with GHT 
and IUGR. As for adverse pregnancy outcome rates, FI 
was found prognostic for umbilical pH and neonatal birth 
weight.
In the assessment of neonatal outcomes rate of apnea it 
was significantly elevated in GHT patients (P = 0.042) com-
pared to CHT patients and it was more significatly elevat-
ed in GHT+GDM (P < 0.001), CHT+GDM (P < 0.001) and PE 
(P = 0.001) cases. One other characteristic perinatal com-
plication specific to newborns of diabetic mothers, hy-
poglycemia was also significantly higher in CHT+GDM 
(P = 0.012) compared to CHT, and GHT+GDM (P = 0.022) 
compared to GHT.
FIGurE 2. Mode of delivery in pregnancies with normal blood pressure (NbP), chronic hypertension (CHT), chronic hypertension 
and gestational diabetes mellitus (CHT+GDM), gestational hypertension (GHT), gestational hypertension and gestational diabetes 
mellitus (GHT+GDM) and preeclampsia (PE).
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DISCuSSION
In our in-vivo study of vascularization analysis we described 
the effect of GDM on placental vascularization and AUtPSV 
in pregnancies complicated with pregnancy hypertension. 
We found no correlation between placental vasculariza-
tion indices (VI, FI and VFI) or AUtPSV findings and mater-
nal age or weeks of gestation.
Because of the chronic intrauterine hypoxia the placen-
tal alterations are presented from first trimester Similarly 
to previous first trimester findings (26). In case of hyper-
tensive disorders of pregnancy (CHT, GHT or PE) placental 
vascularization, which is characterized by FI, is significantly 
lower compared to NBP cases in the second and third tri-
mesters, and it becomes even more affected when hyper-
tension is associated with gestational diabetes (CHT+GDM, 
GHT+GDM) and correlated with the lenght of pathologi-
cal lenght of gestation. On the other hand, according to 
AUtPSV findings, GDM aggravates CHT and GHT hypoxic 
damage of placentas and fetuses. AUtPSV is an absolute 
speed value indicates vascular missing adaptation more 
sensitively than traditional flow indices, such as Systolic-
Diastolic ratio (S/D) or Pulsatility Index (PI).
The increased AUtPSV of diabetic women demonstrated in 
our study reflects changes in systemic arteriolar placental 
afterload, myocardial contractility, heart rate and preload. 
The placenta in diabetic pregnancy has morphological 
changes that may result in reduced uteroplacental perfu-
sion. The absence of a difference in uterine artery PI values 
between fetuses of diabetic women and normal controls 
argues against a modification increased arterial compliance 
may increase AUtPSV without altering afterload (27).
Most studies represent normal Doppler flow in the utero-
placental circulation in pregnancies complicated by ma-
ternal DM, except in those cases complicated by PE (28).
Where women had pre-existing hypertension (CHT cases) 
and normally functioning placenta, we detected no sig-
nificant difference in adverse pregnancy outcome rates 
between CHT and NBP groups despite the lower FI rate, 
though VI was found to be significantly higher in CHT. In 
GHT and PE group, both VI and FI were significantly lower 
(26), as a proof of placental maldevelopment.
Only FI was found to be significantly lower in CHT+GDM 
compared to CHT, though we expected significantly 
lower results in case of VI, VFI as well based on an earlier 
study (22).
AUtPSV in CHT was significantly lower compared to NBP, 
which may be the result of the higher VI rate, and it may 
also confirm the existence of a placental response on 
elevated maternal blood pressure predating preg-
FIGurE 3. Weeks of gestation at the time of 3D scan in pregnancies with normal blood pressure (NbP), chronic hypertension (CHT), 
chronic hypertension and gestational diabetes mellitus (CHT+GDM), gestational hypertension (GHT), gestational hypertension and 
gestational diabetes mellitus (GHT+GDM) and preeclampsia (PE). (N = N2+N3; N2: second trimester, N3: third trimester).
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nancy. Interestingly, the GDM did not trigger the chronic 
hypoxic alteration in CHT group.
There was no significant difference in AUtPSV between 
GHT, PE and NBP, but AUtPSV was significantly higher in 
CHT+GDM compared to both CHT and GHT, which cor-
relates with the higher adverse pregnancy outcome rates 
specific to gestational diabetes mellitus.
The highest mean maternal age was found in case of preg-
nancy hypertension complicated with GDM, highlighting 
the fact that higher maternal age is an important risk fac-
tor in GDM. Above it the GDM has effect on neonatal out-
come, as well. GDM gives a higher rate for hypoglycemic 
episodes and feeding difficulties.
In case of PE there was no further increase in the rate of 
hypoglycemic episodes.
Macrosomia is most likely to occur in case of gestational 
diabetes. In case of NBP, it is possible that there were un-
diagnosed gestational diabetic patients in our NBP group. 
The lower macrosomia rate on the other hand in case of 
GHT+GDM compared to NBP or CHT+GDM might be the 
result of impaired placentation in case of GHT that prevent-
ed GHT+GDM cases end up with macrosomia in neonates.
There are several limitations of our study. The method is 
very sensitive and, therefore, we had to reduce the inter-
observer bias. We should apply standardized settings of 
the ultrasound equipment. Fetal movements and mater-
nal respiratory movements result in artifacts in the 3-DPD 
records. Data recording and analyzing are time consuming, 
thus these kind of investigations are difficult to introduce 
into routine maternal care. The GDM screening is performed 
in first and second trimester based on WHO guideline, it is 
possible that there were undiagnosed gestational diabetic 
patients, which developed in third trimester.
Our study revealed that certain placental vascularization 
indices and AUtPSV may indicate on significant differenc-
es due to gestational pathology, thus placental vascular-
ization indices and AUtPSV can be useful in the early de-
tection of pregnancies at risk in order to possibly prevent 
complications, but extensive researches are requires to de-
termine the clinical significance.
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